[PHAS] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
15-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -20.81%
YoY- -168.07%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 158 0 764 257 0 -
PBT 86,232 -30,375 -11,331 -4,868 -2,535 -
Tax -1,598 -4,071 314 2,975 1,034 -
NP 87,830 -30,375 -11,331 -4,868 -2,535 -
Tax Rate 1.85% - - - - -
Total Cost -87,672 30,375 12,095 5,125 2,535 -
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 55,588.56 -9,492,187,500,000,000.00 -1,483.12 -1,894.16 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 1.82 -1.03 -0.39 -0.26 -0.20 -
EPS Diluted 1.82 -1.03 -0.39 -0.26 -0.20 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.